Patent · US Active

Markers for inflammatory bowel disease

US10228379B2 · kind B2 · utility

0Cited by
2References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 28, 2018
Grant dateMar 12, 2019
Priority date
Expiry dateMay 28, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/065
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided protein biomarkers and methods for their use in diagnosing and treating Inflammatory Bowel Disease (IBD), ulcerative colitis (UC) and Crohn's disease (CD) as well as methods for assessing the severity of the diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.